<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">363882</id>
  <title nil="true"/>
  <common-name>6-bromo-2-sulfanylidene-1,3-benzoxazin-4-one</common-name>
  <description>6-bromo-2-sulfanylidene-1,3-benzoxazin-4-one is a chemical compound with the formula C8H4BrNO2S. It has an average molecular weight of 258.09 g/mol.</description>
  <cas>23611-66-7</cas>
  <pubchem-id>3038271</pubchem-id>
  <chemical-formula>C8H4BrNO2S</chemical-formula>
  <weight>258.09</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-09-01T13:35:10Z</created-at>
  <updated-at type="dateTime">2026-09-01T13:35:10Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=CC2=C(C=C1Br)C(=O)NC(=S)O2</moldb-smiles>
  <moldb-formula>C8H4BrNO2S</moldb-formula>
  <moldb-inchi>InChI=1S/C8H4BrNO2S/c9-4-1-2-6-5(3-4)7(11)10-8(13)12-6/h1-3H,(H,10,11,13)</moldb-inchi>
  <moldb-inchikey>QQLGDOYCSLMRRO-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">256.91461</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>2.3</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM359775</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>6-bromo-2-sulfanylidene-1,3-benzoxazin-4-one</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzoxazines</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0313903</sync-id>
  <structure-inchikey>QQLGDOYCSLMRRO-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>40000000000000000000000000000000000000000000000000000020000200000000800000000000000000000000000000000000000000000000000000000000000000000020800000000000000000800002000200000000000000000000000000100000000400000000000004000000000000000000000000000000000000200000000004000000000000000000000000000000000000004000000000040000080000000000000000000000000000000000000000000000000000000800000108000000000000000000040020004200000000000000a00000000000000040000000000000000000000000000000000000200040</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAANAAAADgAAAIABBkBoAAAAAwMBBkBoAAAA
AwMBBkAoAAAAAwQGQCgAAAADBAZAaAAAAAMDAQZAKAAAAAMEIwAgAAAAAQZA
KAAAAAMECAAoAAAAAwIHQDgAAAADAQMGQCgAAAADBBAAKAAAAAMCCEAoAAAA
AwILAAFoDAECaAwCA2gMAwRoDAQFaAwFBgADB2gMBwgoAgcJaAwJCmgMCgso
AgoMaAwFAGgMDAJoDEICAAAABgAFBAMCAQYHCQoMAgMXBAAAAAAAAAAW
</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T06:00:22Z</structure-indexed-at>
</compound>
